Utility of galactomannan enzyme immunoassay and (1,3) beta-D-glucan in diagnosis of invasive fungal infections: low sensitivity for Aspergillus fumigatus infection in hematologic malignancy patients.

PubWeight™: 1.39‹?› | Rank: Top 5%

🔗 View Article (PMC 2620882)

Published in J Clin Microbiol on November 12, 2008

Authors

R Y Hachem1, D P Kontoyiannis, R F Chemaly, Y Jiang, R Reitzel, I Raad

Author Affiliations

1: Department of Infectious Diseases, Infection Control and Employee Health, Unit 402, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX 77030, USA. rhachem@mdanderson.org

Articles citing this

Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America. Clin Infect Dis (2015) 4.07

Histopathologic diagnosis of fungal infections in the 21st century. Clin Microbiol Rev (2011) 2.27

Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America. Clin Infect Dis (2016) 1.58

Evidence-based guidelines for empirical therapy of neutropenic fever in Korea. Korean J Intern Med (2011) 1.32

Early serum galactomannan trend as a predictor of outcome of invasive aspergillosis. J Clin Microbiol (2012) 1.23

Diagnostic accuracy of serum 1,3-β-D-glucan for pneumocystis jiroveci pneumonia, invasive candidiasis, and invasive aspergillosis: systematic review and meta-analysis. J Clin Microbiol (2011) 1.18

Laboratory diagnosis of invasive aspergillosis: from diagnosis to prediction of outcome. Scientifica (Cairo) (2013) 1.14

Molecular and nonmolecular diagnostic methods for invasive fungal infections. Clin Microbiol Rev (2014) 0.99

Use and limits of (1-3)-β-d-glucan assay (Fungitell), compared to galactomannan determination (Platelia Aspergillus), for diagnosis of invasive aspergillosis. J Clin Microbiol (2014) 0.99

Identification of a putative Crf splice variant and generation of recombinant antibodies for the specific detection of Aspergillus fumigatus. PLoS One (2009) 0.98

β-D-glucan testing is important for diagnosis of invasive fungal infections. J Clin Microbiol (2013) 0.94

Polymerase chain reaction-based assays for the diagnosis of invasive fungal infections. Clin Infect Dis (2012) 0.93

Prospective Evaluation of Serum β-Glucan Testing in Patients With Probable or Proven Fungal Diseases. Open Forum Infect Dis (2016) 0.88

Advancing the Field: Evidence for New Management Strategies in Invasive Fungal Infections. Curr Fungal Infect Rep (2013) 0.87

Analysis of performance of a PCR-based assay to detect DNA of Aspergillus fumigatus in whole blood and serum: a comparative study with clinical samples. J Clin Microbiol (2011) 0.85

Update on the laboratory diagnosis of invasive fungal infections. Mediterr J Hematol Infect Dis (2011) 0.84

(1, 3)-β-D-glucan assay for diagnosing invasive fungal infections in critically ill patients with hematological malignancies. Oncotarget (2016) 0.80

Aspergillus collagen-like genes (acl): identification, sequence polymorphism, and assessment for PCR-based pathogen detection. Appl Environ Microbiol (2013) 0.79

Laboratory Diagnosis of Infections in Cancer Patients: Challenges and Opportunities. J Clin Microbiol (2016) 0.79

State of the art diagnostic of mold diseases: a practical guide for clinicians. Eur J Clin Microbiol Infect Dis (2012) 0.78

The Screening Performance of Serum 1,3-Beta-D-Glucan in Patients with Invasive Fungal Diseases: A Meta-Analysis of Prospective Cohort Studies. PLoS One (2015) 0.77

How to interpret serum levels of beta-glucan for the diagnosis of invasive fungal infections in adult high-risk hematology patients: optimal cut-off levels and confounding factors. Eur J Clin Microbiol Infect Dis (2015) 0.77

Serum galactomannan and (1->3)-β-D-glucan assays for patients with multiple myeloma and Waldenstrom's macroglobulinemia. J Clin Microbiol (2011) 0.76

Diagnosis of Invasive Fungal Diseases in Hematological Malignancies: A Critical Review of Evidence and Turkish Expert Opinion (TEO-2). Turk J Haematol (2014) 0.75

Isolated Aspergillus thyroiditis in an immunocompromised patient. NDT Plus (2010) 0.75

Calcium oxalate in the sputum may aid in the diagnosis of pulmonary aspergillosis: A report of two cases. Med Mycol Case Rep (2015) 0.75

Invasive fungal infection of the central nervous system in a patient with acute myeloid leukaemia. Pol J Radiol (2012) 0.75

Preemptive Antifungal Therapy for Febrile Neutropenic Hematological Malignancy Patients in China. Med Sci Monit (2016) 0.75

Articles cited by this

Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clin Infect Dis (2001) 12.73

Diagnosis of invasive aspergillosis using a galactomannan assay: a meta-analysis. Clin Infect Dis (2006) 5.27

Multicenter clinical evaluation of the (1-->3) beta-D-glucan assay as an aid to diagnosis of fungal infections in humans. Clin Infect Dis (2005) 5.24

Therapeutic outcome in invasive aspergillosis. Clin Infect Dis (1996) 4.83

Galactomannan and computed tomography-based preemptive antifungal therapy in neutropenic patients at high risk for invasive fungal infection: a prospective feasibility study. Clin Infect Dis (2005) 3.96

The epidemiology of fungal infections in patients with hematologic malignancies: the SEIFEM-2004 study. Haematologica (2006) 3.41

Laboratory diagnosis of invasive aspergillosis. Lancet Infect Dis (2005) 3.31

Screening for circulating galactomannan as a noninvasive diagnostic tool for invasive aspergillosis in prolonged neutropenic patients and stem cell transplantation recipients: a prospective validation. Blood (2001) 3.14

Detection of circulating galactomannan for the diagnosis and management of invasive aspergillosis. Lancet Infect Dis (2004) 3.02

Detection of galactomannan antigenemia by enzyme immunoassay for the diagnosis of invasive aspergillosis: variables that affect performance. J Infect Dis (2004) 2.98

Antifungal therapy decreases sensitivity of the Aspergillus galactomannan enzyme immunoassay. Clin Infect Dis (2005) 2.59

Contribution of (1->3)-beta-D-glucan chromogenic assay to diagnosis and therapeutic monitoring of invasive aspergillosis in neutropenic adult patients: a comparison with serial screening for circulating galactomannan. J Clin Microbiol (2005) 2.38

Aspergillus galactomannan detection in the diagnosis of invasive aspergillosis in cancer patients. J Clin Oncol (2002) 2.31

Risks and outcomes of invasive fungal infections in recipients of allogeneic hematopoietic stem cell transplants after nonmyeloablative conditioning. Blood (2003) 2.01

Invasive aspergillosis in allogeneic stem cell transplant recipients: increasing antigenemia is associated with progressive disease. Clin Infect Dis (2002) 1.79

Paradoxical increase in circulating Aspergillus antigen during treatment with caspofungin in a patient with pulmonary aspergillosis. Clin Infect Dis (2006) 1.79

Aspergillus infections: problems in diagnosis and treatment. Infect Agents Dis (1996) 1.78

Value of antigen detection using an enzyme immunoassay in the diagnosis and prediction of invasive aspergillosis in two adult and pediatric hematology units during a 4-year prospective study. Cancer (2001) 1.59

Serum Aspergillus galactomannan antigen testing by sandwich ELISA: practical use in neutropenic patients. J Infect (1997) 1.59

Contribution of the (1-->3)-beta-D-glucan assay for diagnosis of invasive fungal infections. J Clin Microbiol (2007) 1.53

Prospective clinical evaluation of lower cut-offs for galactomannan detection in adult neutropenic cancer patients and haematological stem cell transplant recipients. Br J Haematol (2004) 1.40

Serum glucan levels are not specific for presence of fungal infections in intensive care unit patients. Clin Diagn Lab Immunol (2003) 1.35

Assessment of the clinical utility of serial beta-D-glucan concentrations in patients with persistent neutropenic fever. J Med Microbiol (2008) 1.28

Computed tomographic scan of the chest, latex agglutination test and plasma (1AE3)-beta-D-glucan assay in early diagnosis of invasive pulmonary aspergillosis: a prospective study of 215 patients. Haematologica (2000) 1.27

Combined detection of mannanaemia and antimannan antibodies as a strategy for the diagnosis of systemic infection caused by pathogenic Candida species. J Med Microbiol (2002) 1.23

Incidence and risk factors for invasive fungal infections in allogeneic BMT recipients. Bone Marrow Transplant (1997) 1.19

Prospective assessment of Platelia Aspergillus galactomannan antigen for the diagnosis of invasive aspergillosis in lung transplant recipients. Am J Transplant (2004) 1.14

Invasive pulmonary aspergillosis in patients with hematologic malignancies: survival and prognostic factors. Haematologica (2002) 0.99

Surveillance of Aspergillus galactomannan antigenemia for invasive aspergillosis by enzyme-linked immunosorbent assay in neutropenic patients treated for hematological malignancies. Hematol J (2000) 0.97

Aspergillus galactomannan testing in patients with long-term neutropenia: implications for clinical management. Ann Oncol (2008) 0.93

Microbiological diagnosis of invasive fungal infections in transplant recipients. Transpl Infect Dis (2000) 0.88

Galactomannan antigen enzyme-linked immunosorbent assay for diagnosis of invasive aspergillosis after hematopoietic stem cell transplantation. Biol Blood Marrow Transplant (2007) 0.87

Articles by these authors

Molecular classification of cutaneous malignant melanoma by gene expression profiling. Nature (2000) 15.53

The epidemiology of hematogenous candidiasis caused by different Candida species. Clin Infect Dis (1997) 7.09

A beta peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease. Nature (2001) 6.78

A cortical area selective for visual processing of the human body. Science (2001) 5.92

Contextual cueing: implicit learning and memory of visual context guides spatial attention. Cogn Psychol (1998) 5.17

Role for neuronally derived fractalkine in mediating interactions between neurons and CX3CR1-expressing microglia. Proc Natl Acad Sci U S A (1998) 5.15

Gene expression profiling of alveolar rhabdomyosarcoma with cDNA microarrays. Cancer Res (1998) 4.68

Activation of the transcription factor MEF2C by the MAP kinase p38 in inflammation. Nature (1997) 4.59

Comparative genomic hybridization analysis of 38 breast cancer cell lines: a basis for interpreting complementary DNA microarray data. Cancer Res (2000) 3.83

Characterization of the structure and function of a novel MAP kinase kinase (MKK6). J Biol Chem (1996) 3.63

TRAPP, a highly conserved novel complex on the cis-Golgi that mediates vesicle docking and fusion. EMBO J (1998) 3.49

Assessment of rheumatoid arthritis using a modified scoring method on digitized and original radiographs. Arthritis Rheum (1998) 2.91

Both familial Parkinson's disease mutations accelerate alpha-synuclein aggregation. J Biol Chem (1999) 2.86

DNA microarrays of the complex human cytomegalovirus genome: profiling kinetic class with drug sensitivity of viral gene expression. J Virol (1999) 2.80

Breakthrough zygomycosis after voriconazole administration among patients with hematologic malignancies who receive hematopoietic stem-cell transplants or intensive chemotherapy. Bone Marrow Transplant (2007) 2.74

Posaconazole as salvage therapy for zygomycosis. Antimicrob Agents Chemother (2006) 2.65

Serum antibodies in epilepsy and seizure-associated disorders. Neurology (2005) 2.53

PRAK, a novel protein kinase regulated by the p38 MAP kinase. EMBO J (1998) 2.44

Pharmacokinetics, safety, and efficacy of posaconazole in patients with persistent febrile neutropenia or refractory invasive fungal infection. Antimicrob Agents Chemother (2006) 2.31

Ypt1p implicated in v-SNARE activation. Nature (1994) 2.29

Incidence of invasive aspergillosis following hematopoietic stem cell and solid organ transplantation: interim results of a prospective multicenter surveillance program. Med Mycol (2005) 2.29

Rhinovirus infections in myelosuppressed adult blood and marrow transplant recipients. Clin Infect Dis (1999) 2.28

Mutation of the E6-AP ubiquitin ligase reduces nuclear inclusion frequency while accelerating polyglutamine-induced pathology in SCA1 mice. Neuron (1999) 2.25

Community respiratory virus infections among hospitalized adult bone marrow transplant recipients. Clin Infect Dis (1996) 2.12

Economic burden of smoking in China, 2000. Tob Control (2006) 2.08

Apoptosis signaling pathway in T cells is composed of ICE/Ced-3 family proteases and MAP kinase kinase 6b. Immunity (1997) 2.04

The primary structure of p38 gamma: a new member of p38 group of MAP kinases. Biochem Biophys Res Commun (1996) 1.99

Attributable causes of cancer in China. Ann Oncol (2012) 1.98

Candida krusei fungemia. An escalating serious infection in immunocompromised patients. Arch Intern Med (2000) 1.95

Editors and editing of anti-DNA receptors. Immunity (2001) 1.90

Order of intron removal during splicing of endogenous adenine phosphoribosyltransferase and dihydrofolate reductase pre-mRNA. Mol Cell Biol (1993) 1.85

Resistance to itraconazole in Aspergillus nidulans and Aspergillus fumigatus is conferred by extra copies of the A. nidulans P-450 14alpha-demethylase gene, pdmA. J Antimicrob Chemother (2001) 1.82

Thyroid hormone regulation of hepatic genes in vivo detected by complementary DNA microarray. Mol Endocrinol (2000) 1.73

Long-term effects of a randomised trial of a 6-year lifestyle intervention in impaired glucose tolerance on diabetes-related microvascular complications: the China Da Qing Diabetes Prevention Outcome Study. Diabetologia (2010) 1.68

Cancer incidence among Canadian kidney transplant recipients. Am J Transplant (2007) 1.66

How does peripheral lipopolysaccharide induce gene expression in the brain of rats? Toxicology (2004) 1.65

The Schizosaccharomyces pombe origin recognition complex interacts with multiple AT-rich regions of the replication origin DNA by means of the AT-hook domains of the spOrc4 protein. Proc Natl Acad Sci U S A (2001) 1.64

Characterization of newly emerging Newcastle disease virus isolates from the People's Republic of China and Taiwan. J Clin Microbiol (2001) 1.63

The biocontrol strain Pseudomonas fluorescens F113 produces the Rhizobium small bacteriocin, N-(3-hydroxy-7-cis-tetradecenoyl)homoserine lactone, via HdtS, a putative novel N-acylhomoserine lactone synthase. Microbiology (2000) 1.63

DNA polymerase epsilon may be dispensable for SV40- but not cellular-DNA replication. EMBO J (1996) 1.62

Search for supersymmetry using final states with one lepton, jets, and missing transverse momentum with the ATLAS detector in √s=7 TeV pp collisions. Phys Rev Lett (2011) 1.60

Identification to the species level and differentiation between strains of Aspergillus clinical isolates by automated repetitive-sequence-based PCR. J Clin Microbiol (2004) 1.59

Adenovirus infections in adult recipients of blood and marrow transplants. Clin Infect Dis (2001) 1.57

Photoconductive characteristics of single-crystal CdS nanoribbons. Nano Lett (2006) 1.57

[Correlation between gene expression of CCK-A receptor and gallbladder emptying in gallstone patients]. Zhonghua Wai Ke Za Zhi (1999) 1.56

Markers of inflammation and CD8 T-cell activation, but not monocyte activation, are associated with subclinical carotid artery disease in HIV-infected individuals. HIV Med (2013) 1.56

Protothecosis in patients with cancer: case series and literature review. Clin Microbiol Infect (2003) 1.50

High-dose caspofungin combination antifungal therapy in patients with hematologic malignancies and hematopoietic stem cell transplantation. Bone Marrow Transplant (2007) 1.48

The impact of prior invasive mold infections in leukemia patients who undergo allo-SCT in the era of triazole-based secondary prophylaxis. Bone Marrow Transplant (2012) 1.47

Loss of the retinoblastoma tumor suppressor: differential action on transcriptional programs related to cell cycle control and immune function. Oncogene (2007) 1.45

Endoscopic ultrasonography-guided interstitial implantation of iodine 125-seeds combined with chemotherapy in the treatment of unresectable pancreatic carcinoma: a prospective pilot study. Endoscopy (2008) 1.43

Management of invasive candidal infections: results of a prospective, randomized, multicenter study of fluconazole versus amphotericin B and review of the literature. Clin Infect Dis (1996) 1.43

Infusion therapy team and dressing changes of central venous catheters. Infect Control Hosp Epidemiol (1999) 1.42

Observation of a centrality-dependent dijet asymmetry in lead-lead collisions at sqrt[S(NN)] =2.76 TeV with the ATLAS detector at the LHC. Phys Rev Lett (2010) 1.41

Immunotherapy of tumors with xenogeneic endothelial cells as a vaccine. Nat Med (2000) 1.41

Human glutathione S-transferase P1-1 interacts with TRAF2 and regulates TRAF2-ASK1 signals. Oncogene (2006) 1.40

Measurement of dijet azimuthal decorrelations in pp collisions at sqrt(s)=7  TeV. Phys Rev Lett (2011) 1.39

Parkinson's disease-associated alpha-synuclein is more fibrillogenic than beta- and gamma-synuclein and cannot cross-seed its homologs. J Biol Chem (2000) 1.35

Determination of the strange-quark density of the proton from ATLAS measurements of the W→ℓν and Z→ℓℓ cross sections. Phys Rev Lett (2012) 1.34

Tumor necrosis factor modulates fibroblast apoptosis, PMN recruitment, and osteoclast formation in response to P. gingivalis infection. J Dent Res (2001) 1.34

Hyperbaric oxygen as an adjunctive treatment for zygomycosis. Clin Microbiol Infect (2005) 1.32

Search for new particles in two-jet final states in 7 TeV proton-proton collisions with the ATLAS detector at the LHC. Phys Rev Lett (2010) 1.32

Pulmonary infections mimicking cancer: a retrospective, three-year review. Support Care Cancer (1997) 1.31

Activating mutations of the calcium-sensing receptor: management of hypocalcemia. J Clin Endocrinol Metab (2001) 1.31

An evaluation on smoking-induced health costs in China (1988-1989). Biomed Environ Sci (1995) 1.30

Immunocompromised hosts: immunopharmacology of modern antifungals. Clin Infect Dis (2008) 1.29

Use of the Diversi Lab System for species and strain differentiation of Fusarium species isolates. J Clin Microbiol (2005) 1.28

Identification of a high-risk haplotype for the dystrobrevin binding protein 1 (DTNBP1) gene in the Irish study of high-density schizophrenia families. Mol Psychiatry (2003) 1.28

Observation of associated near-side and away-side long-range correlations in sqrt[s(NN)]=5.02 TeV proton-lead collisions with the ATLAS detector. Phys Rev Lett (2013) 1.27

Reported awareness of tobacco advertising and promotion in China compared to Thailand, Australia and the USA. Tob Control (2009) 1.26

Rho and rho kinase modulation of barrier properties: cultured endothelial cells and intact microvessels of rats and mice. J Physiol (2002) 1.26

Computer-aided diagnosis in radiology: potential and pitfalls. Eur J Radiol (1999) 1.26

12-O-tetradecanoylphorbol-13-acetate-induced apoptosis in LNCaP cells is mediated through ceramide synthase. Cancer Res (1998) 1.25

Molecular characterization and regulation of the aguBA operon, responsible for agmatine utilization in Pseudomonas aeruginosa PAO1. J Bacteriol (2001) 1.24

Validation of nonradioactive chemiluminescent immunoassay methods for the analysis of thyroxine and cortisol in blood samples obtained from dogs, cats, and horses. J Vet Diagn Invest (1997) 1.24

Chromosome arm painting probes. Nat Genet (1996) 1.24

Role of catheter colonization and infrequent hematogenous seeding in catheter-related infections. Eur J Clin Microbiol Infect Dis (1995) 1.24

Infection and immunity in chronic lymphocytic leukemia. Mayo Clin Proc (2000) 1.23

Griffithsin, a potent HIV entry inhibitor, is an excellent candidate for anti-HIV microbicide. J Med Primatol (2007) 1.23

Genome-wide expression changes induced by HTLV-1 Tax: evidence for MLK-3 mixed lineage kinase involvement in Tax-mediated NF-kappaB activation. Oncogene (2001) 1.23

Association of HLA antigens with Vogt-Koyanagi-Harada syndrome in a Han Chinese population. Arch Ophthalmol (1991) 1.22

FP-TDI SNP scoring by manual and statistical procedures: a study of error rates and types. Biotechniques (2003) 1.22

High frequencies of activated B cells and T follicular helper cells are correlated with disease activity in patients with new-onset rheumatoid arthritis. Clin Exp Immunol (2013) 1.21

Voriconazole-associated zygomycosis: a significant consequence of evolving antifungal prophylaxis and immunosuppression practices? Clin Microbiol Infect (2009) 1.19

Search for dark matter candidates and large extra dimensions in events with a photon and missing transverse momentum in pp collision data at sqrt[s]=7 TeV with the ATLAS detector. Phys Rev Lett (2013) 1.19

Study of eight GWAS-identified common variants for association with obesity-related indices in Chinese children at puberty. Int J Obes (Lond) (2011) 1.19

Severity of vertebral fracture reflects deterioration of bone microarchitecture. Osteoporos Int (2006) 1.18

Molecular and genetic aspects of lung cancer. Am J Respir Crit Care Med (2000) 1.17

Crystal structure of the EF-Tu.EF-Ts complex from Thermus thermophilus. Nat Struct Biol (1997) 1.16

Chemokines, a family of chemotactic cytokines. Crit Rev Oral Biol Med (1995) 1.16

Genetic study of indirect inguinal hernia. J Med Genet (1994) 1.16

blaVIM-2 and blaVIM-7 carbapenemase-producing Pseudomonas aeruginosa isolates detected in a tertiary care medical center in the United States: report from the MYSTIC program. J Clin Microbiol (2006) 1.16

A cross-sectional study on levels of second-hand smoke in restaurants and bars in five cities in China. Tob Control (2009) 1.15

Laser microdissection and microarray analysis of breast tumors reveal ER-alpha related genes and pathways. Oncogene (2006) 1.15

Immunogene therapy of tumors with vaccine based on Xenopus homologous vascular endothelial growth factor as a model antigen. Proc Natl Acad Sci U S A (2001) 1.14

Equilibrium states and ground state of two-dimensional fluid foams. Phys Rev E Stat Nonlin Soft Matter Phys (2000) 1.14

Fluconazole versus amphotericin B in the treatment of hematogenous candidiasis: a matched cohort study. Am J Med (1996) 1.14

Rationale for combination antifungal therapy. Pharmacotherapy (2001) 1.14

Risks among siblings and twins for childhood acute lymphoid leukaemia: results from the Swedish Family-Cancer Database. Leukemia (2002) 1.14